Gastric cancer is a common malignancy with a poor prognosis, and surgical treatment
remains the first-line approach to treatment to provide a cure. Despite advances in surgical …

The sixth edition of the Japanese Gastric Cancer Treatment Guidelines was completed in
July 2021, incorporating new evidence that emerged after publication of the previous …

The standard treatment for locally advanced gastric cancer differs across the world. In
western countries, perioperative chemotherapy or postoperative adjuvant …

Gastric adenocarcinoma, even when diagnosed at an early (localized) disease stage, poses
a major health-care burden with cure rates that remain unsatisfactorily low, particularly in …

Patients with gastric cancer are often malnourished during tumor progression. Malnutrition is
a risk factor for postoperative complications and a poor prognosis. Early evaluation and …

Background Recent studies have found a negative impact of postoperative complications on
long-term survival outcomes, but it has not been confirmed by data obtained from a …

The position of abdominal organs, and mechanisms by which these are centrally connected,
are currently described in peritoneal terms. As part of the peritoneal model of abdominal …

Background Sarcopenia and obesity are associated with outcomes after surgery. However,
few studies have investigated which more accurately predicts postoperative complications or …

Background Adding anti-angiogenics to neoadjuvant chemotherapy for localized gastric
cancer is recognized as a promising strategy, but its clinical value remains to be defined …

Background Microsatellite instability (MSI) and programmed death-ligand 1 (PD-L1) are
candidate predictors for the response to immune checkpoint inhibitors, and may predict …